Lipicky R J, Gilbert D L, Ehrenstein G
Biophys J. 1978 Nov;24(2):405-22. doi: 10.1016/S0006-3495(78)85391-0.
Yohimbine, an indolealkylamine alkaloid, reduces the amplitude of the sodium current in the squid giant axon. For doses that reduce sodium current amplitude by up to 50%, there is no significant change in the kinetics or in any of the voltage-dependent parameters associated with sodium channels. The effective equilibrium constant for yohimbine binding to the sodium channel is 3 x 10(-4) M. Repetitive depolarizing pulses increase the inhibition of squid axon sodium current by yohimbine. This use-dependent inhibition is enhanced by increasing the concentration of yohimbine, by increasing the frequency of pulsing, and by increasing the magnitude or the duration of depolarization. It is reduced by hyperpolarizing prepulses. This behavior can be explained by a model wherein yohimbine binds more readily to open sodium channels than to closed sodium channels and wherein the Hodgkin-Huxley kinetic parameters are modified by the binding of the drug. This type of model may also explain the tonic and use-dependent inhibition previously described by others for local anesthetics.
育亨宾是一种吲哚烷基胺生物碱,可降低枪乌贼巨大轴突中钠电流的幅度。对于能使钠电流幅度降低达50%的剂量,其动力学或与钠通道相关的任何电压依赖性参数均无显著变化。育亨宾与钠通道结合的有效平衡常数为3×10⁻⁴ M。重复性去极化脉冲会增强育亨宾对枪乌贼轴突钠电流的抑制作用。这种使用依赖性抑制可通过增加育亨宾浓度、增加脉冲频率以及增加去极化的幅度或持续时间来增强。通过超极化预脉冲可使其减弱。这种行为可用一个模型来解释,即育亨宾与开放的钠通道结合比与关闭的钠通道更容易,且药物结合会改变霍奇金 - 赫胥黎动力学参数。这种模型类型也可能解释其他人先前描述的局部麻醉药的强直和使用依赖性抑制。